Explore Mario, Su and more!

Explore related topics

Mario Melazzini su incarico in AIFA, sperimentazioni e ruolo del paziente esperto

Mario Melazzini su incarico in AIFA, sperimentazioni e ruolo del paziente esperto

How AstraZeneca cancer drug forecasts are set to rise

How AstraZeneca cancer drug forecasts are set to rise

Trusted Coach On Things That Matter.

Did the FDA set 'a dangerous precedent' with its latest drug approval?

Did the FDA set 'a dangerous precedent' with its latest drug approval?

New guidance issued by the US Food and Drug Administration (FDA) is intended to clarify the process of "marking" a medical device with a Unique Device Identifier (UDI).

Eliquis smashes rivals Xarelto, Pradaxa at cutting bleed-related costs in real-world study

Eliquis smashes rivals Xarelto, Pradaxa at cutting bleed-related costs in real-world study

Boehringer starts to feel impact of Spiriva generics

Boehringer starts to feel impact of Spiriva generics

Patients Fear Spike in Price of Old Drugs - The New York Times

Patients Fear Spike in Price of Old Drugs

Patients Fear Spike in Price of Old Drugs - The New York Times

Waste in Cancer Drugs Costs $3 Billion a Year, a Study Says - The New York Times

Waste in Cancer Drugs Costs $3 Billion a Year, a Study Says

Waste in Cancer Drugs Costs $3 Billion a Year, a Study Says - The New York Times

Antimicrobial resistance will kill 300 million by 2050 without action | Chemistry World

Antimicrobial resistance will kill 300 million by 2050 without action | Chemistry World

New drug approvals fall to six-year low in 2016

New drug approvals fall to six-year low in 2016

Last year turned out to be a disappointing one for new drug approvals with the U. Food and Drug Administration clearing just 22 new medicines for sale, the lowest number since 2010 and sharply down on tally of

Pinterest
Search